Production and characterization of monoclonal antibodies against the Epstein-Barr virus membrane antigen.
AUTOR(ES)
Strnad, B C
RESUMO
Five murine hybridoma lines that produce monoclonal antibodies against Epstein-Barr virus membrane antigen (MA) were established. Immunoprecipitation experiments demonstrated that three of the antibodies precipitated both the 236,000 (236K) MA and the 212K MA. The other two antibodies precipitated the 86K MA. Antibodies against the 236K-212K MA and the 86K MA mediated complement-dependent cytolysis of Epstein-Barr-virus-infected cells. The antibodies against the 86K MA neutralized both the B95-8 and P3HR-1 viruses.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=256747Documentos Relacionados
- Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen.
- Papain solubilization of the Epstein-Barr virus-induced membrane antigen.
- Antibodies against synthetic peptides react with the second Epstein-Barr virus-associated nuclear antigen.
- Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen.
- Improved immunofluorescence antigens for detection of immunoglobulin M antibodies to Epstein-Barr viral capsid antigen and antibodies to Epstein-Barr virus nuclear antigen.
